IOVANCE BIOTHERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $149.3M | $701.3M | $92.4M |
| Jun 2022 | $138.2M | $610.9M | $108.1M |
| Sep 2022 | $152.2M | $545.9M | $118.4M |
| Dec 2022 | $164.3M | $664.0M | $231.7M |
| Mar 2023 | $157.9M | $824.8M | $543.5M |
| Jun 2023 | $178.7M | $757.3M | $230.0M |
| Sep 2023 | $178.3M | $852.3M | $267.7M |
| Dec 2023 | $195.7M | $780.4M | $114.9M |
| Mar 2024 | $189.8M | $869.8M | $134.2M |
| Jun 2024 | $195.8M | $964.3M | $228.7M |
| Sep 2024 | $217.7M | $991.1M | $164.2M |
| Dec 2024 | $200.0M | $910.4M | $115.7M |
| Mar 2025 | $198.9M | $966.7M | $171.7M |
| Jun 2025 | $208.9M | $907.4M | $132.5M |
| Sep 2025 | $202.7M | $904.9M | $158.1M |
| Dec 2025 | $214.6M | $913.2M | $163.1M |
| Mar 2026 | $203.9M | $925.7M | $196.5M |
| Jun 2026 | $179.5M | $915.5M | $110.8M |